By Alex Gavrish, Etalon Investment Research; author of "Wall Street Back To Basics" The main beneficiary of a recent acquisition of Idenix Pharmaceuticals Inc ( IDIX) by Merck & Co., Inc. ( MRK) is Baupost Group, an investment management firm managed by Seth Klarman, a famous value investor. Baupost Group owns a large 35% stake in the company and stands to profit handsomely once the deal completes. While Klarman’s firm was quite a long term shareholder, another, smaller investor had caught our attention. Sarissa Capital, a recently launched activist hedge fund focused on healthcare investments. The fund owned 5.05 milliom shares, valued at $36.5 million based on Idenix’s market price before deal announcement. The fund just started, in 2013, to make investments and one of its main portfolio holding, as of March 31st, 2014, was Idenix. As of March 31st, 2013, position represented 11% out of a total $290 million portfolio. We decided to dig deeper and review the fund’s other holdings.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Chip Stocks Look More Intriguing After Their Recent Plunge
While it's possible that trade tensions will lead chip stocks to sell off farther, a lot has already been priced in, and it's not a given that worst-case fears will be realized.
Tesla's Troubles: 4 Things Elon Musk Needs to Do Now to Restore Confidence
With Tesla shares now at their lowest level in two-and-a-half years, investors need reassurance that the carmaker is on the right path.
Inconsistent Trading Action and Counter-Trend Bounces: Welcome to This Market
Market players were anxious for a bounce and they created one.
Stocks Finish Higher, Tech Shares Rebound as U.S. Eases Huawei Restrictions
Stocks finish higher Tuesday as the Commerce Department eases restrictions on China's Huawei.